Conference Overview

4th Scientific Conference of Ethiopia Field Epidemiology and Laboratory Training Program (EFELTP)

Conference Subthemes

Conference Tracks

1. Public Health Emergency Preparedness, Surveillance, Outbreak Investigations and Response

• - Emerging and re-emerging pandemic threats
• - Outbreak Preparedness, Investigation and Response
• - Point of Entry Surveillance and Cross border collaborations
• - Refugee and Internally Displace Person's health issues
• - Integrated Disease Surveillance and Response (IDSR)
• - Public health surveillance system assessment

2. Vaccine Preventable Diseases

• - Polio and Acute Flaccid Paralysis (AFP) surveillance
• - Measles and Rubella Surveillance
• - Recently introduced vaccines in developing countries
• - Surveillance and control of other vaccine preventable diseases
• - KAP survey on VPD diseases

3. HIV/AIDS, Tuberculosis and Other Opportunistic Infections

• - Healthcare delivery and prevention models for HIV/AIDS
• - Tuberculosis including drug resistant TB
• - Other opportunistic infections and malignancies
• - HIV CBS

Abstract Submission Guidelines

Abstract Submission Guidelines

• Abstract should be written in English language.

• Residents and graduates should upload their abstracts via the abstract submission portal.

• Conflict of interest and biographical information: Authors of accepted abstracts will be asked to submit a disclosure of conflict-of-interest form. Biographical information will also be collected to facilitate continuing education accreditation of the conference.

Structure of Abstracts:

• Title: The title should be informative but concise. Avoid subtitles if possible. Write the title in Sentence case and only capitalize proper nouns and scientific names where appropriate (e.g., Plasmodium falciparum). Do NOT use abbreviations or acronyms in the abstract title.
• Introduction/Background: Address the scientific background, rationale for the study as well as the public health significance of the subject.
  • A brief description of the topic and its public health significance
  • Study Objectives
  • Research questions or study hypothesis if applicable
• Methods: Describe the methods used for the study, including:
  • Study design
  • Study setting
  • Study population
  • Eligibility criteria and case definitions if any
  • Sample size and sampling methods
  • Data management and analysis processes
• Results: Present the significant/key findings (both positive and negative) of the study that are directly related to the study objectives. The results section should contain data, not statements such as “Data will be discussed.” If considerable work is still pending, indicate that the results are preliminary.
• Conclusion: Be as concise as possible. Do not re-state data included in the results. This section may include:
  • An interpretation of key findings and their implications for public health practice
  • Public health actions that are recommended and/or have been implemented as a consequence of the study

Note: Changes cannot be made to the final abstract after submission. However, if significant changes occur, they should be highlighted during presentation.

Word Count

The abstract should not exceed 300 words (includes sub-headings but does not include the title, keywords, list of authors and their addresses).

Formatting

• Text should be left aligned.
• Use font Times New Roman, Calibri, or Arial, size 12, and 1.5 spacing.
• Each sub-heading should be in bold font, and followed by a colon.
• Do not include any tables, figures, or pictures in the abstract.
• Avoid using abbreviations that are not standard; where used, they should be written in full the first time they appear.
• Scientific names should be italicized.

Authors

• First author: Provide first name, initials of the middle name (if any), and the last name (e.g., David W. Meyers).
• Co-authors: List each co-author in order of contribution by typing their first and middle names as initials followed by their last name in full (e.g., W. Grisham, M. S. Pollock).
• Provide the organizational affiliations of the first author and all co-authors.
• Indicate the corresponding author with an asterisk * and provide their email address and telephone number along with alternate contacts.

Keywords

Please include 4–6 keywords. Use terms listed in the Medical Subject Headings (MeSH) from the Index Medicus (http://www.nlm.nih.gov/mesh/meshhome.html).

Evaluation Criteria

Each abstract will be evaluated by three independent reviewers using the following criteria:

• Background and rationale of the study
• Appropriateness of methods
• Presentation of results
• Conclusion and interpretation of results
• Public health significance
• Overall clarity of the abstract
• Novelty of the study

Further questions concerning the abstract submission should be addressed to the Chair or Co-Chair of the Scientific Committee at Email: [Email Address]

For further details about the 4th EFELTP Scientific Conference, contact [Contact Information] or visit the conference website at www.afenet-conference.net.